AstraZeneca (AZN)

Date of interaction: 17/07/19

Investment institution: BMO Global Asset Management

Type of interaction: Email exchange

Name of investor representative:

Catherine Hoyle

Role of company contact(s): Sustainability

Did the conversation take place with the head office or a regional division? HQ

Company engagement level following engagement: Engaging

Did the company cite any of the following barriers to disclosing to the WDI?

Agreed follow-up actions and timeline for investor and/or WDI team:

Dedicated letter highlighting our support of the WDI & encouraged the company to respond to the 2019 survey. We will follow-up mid August.

What were the main workforce topics discussed during the engagement?